
Senior Manager, Corporate Communications and Patient Advocacy
Nuvation Bio
New York, USA (On-site)
Posted 5 months ago
The other 99% submit and hope. You're about to do something different.
Drive biotech corporate communications and patient advocacy for Nuvation Bio, shaping messaging, media relations, and stakeholder engagement at scale.
Nuvation Bio is a global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s portfolio includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in New York, San Francisco, and Shanghai.